Efficacy of bile acid therapy for gallstone dissolution: a meta‐analysis of randomized trials
Authors:
- 1 April 1993
- journal article
- clinical trial
- Published by Wiley in Alimentary Pharmacology & Therapeutics
- Vol. 7 (2) , 139-148
Abstract
SUMMARY: To define better the efficacy of bile acid therapy for dissolution of radiolucent gallstones, we performed a meta‐analysis of published trials from January 1966 to September 1992. Studies were identified using a MEDLINE computer search followed by an extensive manual search. The inclusion criteria used were: randomized trial, radiolucent gallstones in a visualizing gallbladder on oral cholecystography, and complete stone dissolution confirmed by oral cholecystography or ultrasound. Study results were pooled into 6 groups: placebo: high‐ and low‐dose chenodeoxycholic acid (CDCA) (≥10 mg.kg/day and < 10 mg.kg/day); high‐ and low‐dose ursodeoxycholic acid (UDCA) (< 7 mg. kg/day and < 7 mg. kg/day) and combined CDCA plus UDCA. Homogeneity calculations were performed and the percentage of complete stone dissolution calculated for each group with 95% confidence intervals. Of 66 trials identified, 23 comprising 1949 patients met the inclusion criteria. A total of 1062 patients were treated with CDCA, 819 with UDCA and 78 combination therapy. In studies > 6 months' duration, high‐dose UDCA completely dissolved stones in 37.3% of patients (95% C.I. 33–42%), low‐dose UDCA in 20.6%) and high‐dose CDCA 18.2% (95% C.I. 15–21%). Based on only two studies, combination therapy achieved dissolution in 62.8% (95% C.I. 51–74%) of patients. Stones less than 10 mm dissolved significantly more frequently than stones larger than 10 mm. This analysis shows that UDCA in doses greater than 7 mg. kg/day taken for greater than 6 months will dissolve radiolucent gallstones in 38% of patients. The combination of UDCA and CDCA may be more efficacious but this observation is based upon only 78 patients and requires confirmation in further randomized trials.Keywords
This publication has 55 references indexed in Scilit:
- Meta-Analyses of Randomized Controlled TrialsNew England Journal of Medicine, 1987
- Gallstone dissolution treatment with a combination of chenodeoxycholic and ursodeoxycholic acidsDigestive Diseases and Sciences, 1986
- Meta-analysis in clinical trialsControlled Clinical Trials, 1986
- Gallstone dissolution with ursodeoxycholic acid in patients with chronic active hepatitis and two years follow-upDigestive Diseases and Sciences, 1985
- Drug and treatment efficacy of chenodeoxycholic acid in 97 patients with cholelithiasis and increased surgical riskDigestive Diseases and Sciences, 1983
- A method for assessing the quality of a randomized control trialControlled Clinical Trials, 1981
- Low-dose chenodeoxycholic acid for gallstone dissolution: A randomized trial in poor operative risk patientsDigestive Diseases and Sciences, 1980
- Chenotherapy for gallstone dissolution. I. Efficacy and safetyJAMA, 1978
- Feasibility of low-dose and intermittent chenodeoxycholic acid therapy of gallstonesDigestive Diseases and Sciences, 1977
- The Medical Treatment of Cholesterol Gallstones: Experience with Chenodeoxycholic AcidDigestion, 1976